Connie Slaughter
Nurse Practitioner · Navarre, FLNPI 1104141928
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 31.8% of the total. Reporting peaked in 2022 at $103 and has fallen 72.6% since, to $28 in 2025. That places this record below the midpoint for nurse practitioner clinicians in FL, where the typical reported total is $188.
Across 16 payments — averaging $14.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$76
- Lilly USA, LLC$52
- Amgen$42
- Johnson & Johnson$25
- Supernus Pharmaceuticals, Inc.$20
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$19
- plus $5 from 1 others
What the payments were for
- Food & beverage$238100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 5 | $76 |
| Lilly USA, LLC | 3 | $52 |
| Amgen | 3 | $42 |
| Johnson & Johnson | 2 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Genentech USA, Inc. | 1 | $5 |
How this compares
$238 in reported general payments places this provider in the 50th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 41 | $408 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 18 | $348 |
| Methylprednisolone | 35 | $288 |
| Doxycycline Hyclate | 24 | $245 |
| Cephalexin | 41 | $214 |
| Prednisone | 54 | $133 |
| Fluconazole | 17 | $119 |
| Azithromycin | 29 | $100 |
| Levofloxacin | 12 | $96 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Navarre
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.